# Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

> **NCT02911844** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 5 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Fulvestrant

## Key facts

- **NCT ID:** NCT02911844
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-10
- **Primary completion:** 2018-12-05
- **Final completion:** 2018-12-05
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911844, "Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02911844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*